Applied DNA Sciences prices $6.5M registered direct and private placement

BNB PLUS CORP.

Gross proceeds ~$6.5M from sale of 20.3M shares (or pre-funded warrants) at $0.32 per share.
Issues Series C and D warrants to purchase 20.3M shares each, both exercisable at $0.32 after stockholder approval.
Series D exercise price resets to lower of $0.32 or lowest VWAP around a future reverse split, floor $0.0634.
Amends existing Series A warrants to set floor price at $0.20 for price protection provisions.
Net proceeds for therapeutic DNA production services development and general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.